Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
![]() SLEMAN, Marwa, VETRILĂ, Snejana, IVANES, Anastasia. Cardiac resynchronization therapy in patient with HFrEF. In: MedEspera: International Medical Congress for Students and Young Doctors, Ed. 9th edition, 12-14 mai 2022, Chişinău. Chisinau, Republic of Moldova: 2022, 9, p. 18. ISBN 978-9975-3544-2-4. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
MedEspera 9, 2022 |
||||||
Congresul "International Medical Congress for Students and Young Doctors" 9th edition, Chişinău, Moldova, 12-14 mai 2022 | ||||||
|
||||||
Pag. 18-18 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Introduction. Heart failure (HF) is a global pandemic clinical syndrome at least affecting 26 million people around the world and is still increasing dramatically in prevalence especially among the aging population despite the significant advances in therapies and preventions. The prevalence increases with age: from around 1% for those aged <55 years to >10% in those aged 70 years or over. It is generally believed that of those with HF, about 50% have heart failure with reduced ejection fraction (HFrEF). Pharmacotherapy is the cornerstone of treatment for HFrEF and should be implemented before considering device therapy, and alongside non-pharmacological interventions. In appropriately selected individuals, cardiac resynchronization therapy (CRT) reduces morbidity, mortality, improves cardiac function and enhances QOL. |
||||||
|